Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...

COLUMBUS, Ohio--(BUSINESS WIRE)--Worthington Steel Completes Acquisition of Kloeckner & Co and Announces Intention to Launch Delisting Tender Offer...

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it has entered into a Restructuring Support Agreement (“RSA”) with its Prepetition First Lien Lenders and Ad Hoc Group of Noteholders, constituting substantially all of its junior creditors, to implemen...

LONDON--(BUSINESS WIRE)--  DMO-TAS031/3678/004 The Minster Building 21 Mincing Lane London EC3R 7AG T 020 7862 6500 F 020 7862 6509 www.dmo.gov.uk         3 June 2026 A072\26   PRESS NOTICE   RESULT OF THE SALE BY AUCTION OF £1,600 MILLION OF 1⅛% INDEX-LINKED TREASURY GILT 2035 The United Kingdom Debt Management Office ("DMO") announces that the auction of £1,600 million of 1⅛% Index-linked Treasury Gilt 2035 (ISIN code: GB00BT7HZZ68) has been allocated as follows: (Note: all prices in this not...

PARIS & SEATTLE--(BUSINESS WIRE)--Aircall acquires Piper AI to turn customer conversations into revenue action by automating CRM updates, deal scoring, and next steps across channels....

PARIS ET SEATTLE--(BUSINESS WIRE)--Aircall, la plateforme de communication client augmentée par l’IA à laquelle plus de 23 000 entreprises font confiance dans le monde, a annoncé aujourd’hui l’acquisition de Piper AI, une entreprise spécialisée en Revenue Intelligence et orchestration commerciale via agent IA. Avec Piper, Aircall fait évoluer sa plateforme au-delà des conversations, en fournissant aux équipes commerciales les outils nécessaires pour automatiser chaque interaction, sur tous les...

PARÍS Y SEATTLE--(BUSINESS WIRE)--Aircall, la plataforma de comunicaciones impulsada por IA en la que confían más de 23 000 empresas en todo el mundo, anunció hoy la adquisición de Piper AI, una empresa especializada en inteligencia de ingresos y coordinación agéntica de ventas. Con Piper, Aircall amplía su plataforma más allá de la conversación en sí, proporcionando a los equipos de ventas las herramientas necesarias para actuar automáticamente sobre cada interacción, a través de cada canal, d...

PARIS/ SEATTLE--(BUSINESS WIRE)--Aircall, die KI-gestützte Kommunikationsplattform, der mehr als 23.000 Unternehmen weltweit vertrauen, gibt die Übernahme von Piper AI bekannt — einem Unternehmen für Revenue Intelligence und agentische Sales-Orchestrierung. Mit Piper erweitert Aircall seine Plattform über das Gespräch selbst hinaus und gibt Vertriebsteams die Möglichkeit, nach jeder Interaktion automatisch zu handeln, kanalübergreifend und über den gesamten Sales-Zyklus hinweg. Aircall vereint...

WARSAW, Poland--(BUSINESS WIRE)--Rezon Bio, a science-driven European biologics contract development and manufacturing organization (CDMO), today announced the appointment of Dr. Ralf Otto, as Chief Operating Officer (COO) effective June 1, 2026. In his role, Ralf Otto, PhD, will be responsible for the operational areas of clinical and commercial cGMP manufacturing, development, quality, engineering and business operations across Rezon Bio’s integrated end-to-end CDMO platform. His appointment...